PubMed

Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes.

Qin X, Goldfine A, Krumrei N, Grubissich L, Acosta J, Chorev M, Hays AP, Halperin JA.

Diabetes. 2004 Oct;53(10):2653-61.PMID: 15448097 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular basis for a link between complement and the vascular complications of diabetes.

Acosta J, Hettinga J, Flückiger R, Krumrei N, Goldfine A, Angarita L, Halperin J.

Proc Natl Acad Sci U S A. 2000 May 9;97(10):5450-5.PMID: 10805801 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.

Ramo K, Cashman SM, Kumar-Singh R.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4126-36. Epub 2008 May 16.PMID: 18487376 [PubMed - indexed for MEDLINE]Related articlesFree article

An engineered bifunctional recombinant molecule that regulates humoral and cellular effector functions of the immune system.

Pizzolato MC, Fodor WL.

Transplantation. 2003 Feb 27;75(4):542-9.PMID: 12605124 [PubMed - indexed for MEDLINE]Related articles

The effect of glycation of CD59 on complement-mediated cytolysis.

Cheng Y, Gao M.

Cell Mol Immunol. 2005 Aug;2(4):313-7.PMID: 16274631 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects.

Davies CS, Harris CL, Morgan BP.

Immunology. 2005 Feb;114(2):280-6.PMID: 15667573 [PubMed - indexed for MEDLINE]Related articlesFree article

CD59 protects rat kidney from complement mediated injury in collaboration with crry.

Watanabe M, Morita Y, Mizuno M, Nishikawa K, Yuzawa Y, Hotta N, Morgan BP, Okada N, Okada H, Matsuo S.

Kidney Int. 2000 Oct;58(4):1569-79.PMID: 11012891 [PubMed - indexed for MEDLINE]Related articlesFree article

Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.

He C, Imai M, Song H, Quigg RJ, Tomlinson S.

J Immunol. 2005 May 1;174(9):5750-7.PMID: 15843577 [PubMed - indexed for MEDLINE]Related articlesFree article

Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.

Zhou CY, McInnes E, Copeman L, Langford G, Parsons N, Lancaster R, Richards A, Carrington C, Thompson S.

Xenotransplantation. 2005 Mar;12(2):142-8.PMID: 15693845 [PubMed - indexed for MEDLINE]Related articles

Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda.

Vasil KE, Magro CM.

J Am Acad Dermatol. 2007 Jan;56(1):96-104.PMID: 17190626 [PubMed - indexed for MEDLINE]Related articles

[Coexpression of human complement regulatory protein genes, CD59 and MCP in transgenic mice protects isolated mouse heart function in ex vivo human plasma perfusion model]

Xie L, Zhu M, Wang SS, Li R, Zeng MH, Huang YB, Wang L, Guo H, Wei QX, Li WX, Chen S.

Zhonghua Yi Xue Za Zhi. 2005 Nov 9;85(42):3001-4. Chinese. PMID: 16324389 [PubMed - indexed for MEDLINE]Related articles

Elimination of potential sites of glycosylation fails to abrogate complement regulatory function of cell surface CD59.

Rother RP, Zhao J, Zhou Q, Sims PJ.

J Biol Chem. 1996 Sep 27;271(39):23842-5.PMID: 8798614 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of mutations in rat CD59 that increase the complement regulatory activity.

Hinchliffe SJ, Morgan BP.

Biochemistry. 2000 May 16;39(19):5831-7.PMID: 10801333 [PubMed - indexed for MEDLINE]Related articles

Targeting of functional antibody-CD59 fusion proteins to a cell surface.

Zhang HF, Yu J, Bajwa E, Morrison SL, Tomlinson S.

J Clin Invest. 1999 Jan;103(1):55-61.PMID: 9884334 [PubMed - indexed for MEDLINE]Related articlesFree article

The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

van den Berg CW, Harrison RA, Morgan BP.

Immunology. 1993 Mar;78(3):349-57.PMID: 7682985 [PubMed - indexed for MEDLINE]Related articlesFree article

A novel advanced glycation index and its association with diabetes and microangiopathy.

Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.

Metabolism. 2005 Aug;54(8):1002-7.PMID: 16092048 [PubMed - indexed for MEDLINE]Related articles

Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Tada T, Okada H, Okada N, Tateyama H, Suzuki H, Takahashi Y, Eimoto T.

Virchows Arch. 1997 Apr;430(4):327-32.PMID: 9134044 [PubMed - indexed for MEDLINE]Related articles

The role of protein kinase C activation and the vascular complications of diabetes.

Das Evcimen N, King GL.

Pharmacol Res. 2007 Jun;55(6):498-510. Epub 2007 May 5. Review.PMID: 17574431 [PubMed - indexed for MEDLINE]Related articles

Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.

Uesugi N, Sakata N, Nangaku M, Abe M, Horiuchi S, Hisano S, Iwasaki H.

Am J Kidney Dis. 2004 Aug;44(2):224-38.PMID: 15264180 [PubMed - indexed for MEDLINE]Related articles

Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.

Väkevä A, Lehto T, Takala A, Meri S.

Scand J Immunol. 2000 Oct;52(4):411-4.PMID: 11013013 [PubMed - indexed for MEDLINE]Related articles